Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association - PubMed (original) (raw)
. 2019 Apr 16;139(16):e840-e878.
doi: 10.1161/CIR.0000000000000664.
Vivek Bhalla, John E A Blair, Tara I Chang, Salvatore Costa, Krista L Lentine, Edgar V Lerma, Kenechukwu Mezue, Mark Molitch, Wilfried Mullens, Claudio Ronco, W H Wilson Tang, Peter A McCullough; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology
- PMID: 30852913
- DOI: 10.1161/CIR.0000000000000664
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
Janani Rangaswami et al. Circulation. 2019.
Abstract
Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic dysfunction in the other organ. It represents the confluence of heart-kidney interactions across several interfaces. These include the hemodynamic cross-talk between the failing heart and the response of the kidneys and vice versa, as well as alterations in neurohormonal markers and inflammatory molecular signatures characteristic of its clinical phenotypes. The mission of this scientific statement is to describe the epidemiology and pathogenesis of cardiorenal syndrome in the context of the continuously evolving nature of its clinicopathological description over the past decade. It also describes diagnostic and therapeutic strategies applicable to cardiorenal syndrome, summarizes cardiac-kidney interactions in special populations such as patients with diabetes mellitus and kidney transplant recipients, and emphasizes the role of palliative care in patients with cardiorenal syndrome. Finally, it outlines the need for a cardiorenal education track that will guide future cardiorenal trials and integrate the clinical and research needs of this important field in the future.
Keywords: AHA Scientific Statements; acute kidney injury; biomarkers; cardio-renal syndrome; chronic kidney disease; dialysis; diuretics; heart failure; hospitalization; kidney transplantation; mortality; ultrafiltration.
Similar articles
- A Clinical Approach to the Acute Cardiorenal Syndrome.
Jentzer JC, Chawla LS. Jentzer JC, et al. Crit Care Clin. 2015 Oct;31(4):685-703. doi: 10.1016/j.ccc.2015.06.006. Crit Care Clin. 2015. PMID: 26410138 Review. - [CARDIORENAL SYNDROME: CLINICAL FEATURES, EARLY DIAGNOSIS AND TREATMENT AT FAMILY MEDICINE].
Marković BB. Marković BB. Acta Med Croatica. 2016 Dec;70(4-5):207-16. Acta Med Croatica. 2016. PMID: 29087099 Review. Croatian. - Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes.
Cruz DN. Cruz DN. Adv Chronic Kidney Dis. 2013 Jan;20(1):56-66. doi: 10.1053/j.ackd.2012.10.005. Adv Chronic Kidney Dis. 2013. PMID: 23265597 Review. - Cardiorenal Syndrome in Acute Kidney Injury.
Di Lullo L, Reeves PB, Bellasi A, Ronco C. Di Lullo L, et al. Semin Nephrol. 2019 Jan;39(1):31-40. doi: 10.1016/j.semnephrol.2018.10.003. Semin Nephrol. 2019. PMID: 30606406 Review. - [PATHOPHYSIOLOGY OF THE CARDIORENAL SYNDROME].
Balint I, Vučak J, Bašić-Marković N, Klarić D, Šakić VA. Balint I, et al. Acta Med Croatica. 2016 Dec;70(4-5):325-31. Acta Med Croatica. 2016. PMID: 29087629 Review. Croatian.
Cited by
- Application of functional magnetic resonance imaging to evaluate renal structure and function in type 2 cardiorenal syndrome.
Jin L, Zong Y, Pan Y, Hu Y, Xie Q, Wang Z. Jin L, et al. BMC Cardiovasc Disord. 2024 Nov 13;24(1):637. doi: 10.1186/s12872-024-04324-w. BMC Cardiovasc Disord. 2024. PMID: 39538120 Free PMC article. - A Nomogram Incorporating Inflammation and Nutrition Indexes for Predicting Outcomes in Patients with Acute Coronary Syndrome and Chronic Kidney Disease.
Ni W, Pan ZZ, Zhou H. Ni W, et al. J Inflamm Res. 2024 Nov 4;17:8181-8198. doi: 10.2147/JIR.S488674. eCollection 2024. J Inflamm Res. 2024. PMID: 39525313 Free PMC article. - Effective tricuspid regurgitation reduction is associated with renal improvement and reduced heart failure hospitalization.
Felbel D, von Winkler J, Paukovitsch M, Gröger M, Walther E, Andreß S, Schneider L, Markovic S, Rottbauer W, Keßler M. Felbel D, et al. Front Cardiovasc Med. 2024 Oct 21;11:1452446. doi: 10.3389/fcvm.2024.1452446. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39498353 Free PMC article. - Semaglutide cuts kidney risk in obesity.
Giugliano D, De Nicola L, Maiorino MI, Esposito K. Giugliano D, et al. J Endocrinol Invest. 2024 Nov 4. doi: 10.1007/s40618-024-02494-0. Online ahead of print. J Endocrinol Invest. 2024. PMID: 39495477 No abstract available. - Device therapies for heart failure with reduced ejection fraction: a new era.
Mody R, Nee Sheth AB, Dash D, Mody B, Agrawal A, Monga IS, Rastogi L, Munjal A. Mody R, et al. Front Cardiovasc Med. 2024 Oct 18;11:1388232. doi: 10.3389/fcvm.2024.1388232. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39494238 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous